(Q46931461)

26 December 2017

title

Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine (English)

1 reference

26 December 2017

author name string

Iclal Yücel

1

1 reference

26 December 2017

Gültekin Yücel

2

1 reference

26 December 2017

Yusuf Akar

3

1 reference

26 December 2017

Necdet Demir

4

1 reference

26 December 2017

Nilgün Gürbüz

5

1 reference

26 December 2017

Mutay Aslan

6

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

Canadian Journal of Ophthalmology

published in

1 reference

26 December 2017

volume

41

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

60-66

1 reference

26 December 2017

Altered epithelial-basement membrane interactions in diabetic corneas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Corneal epithelial changes in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

The maillard or browning reaction in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Therapeutic potential of breakers of advanced glycation end product–protein crosslinks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Investigation of Corneal Autofluorescence in Diabetic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to N∊-carboxymethyl-lysine- and N∊-(1-carboxyethyl)lysine-modified albu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Nitric oxide synthases: structure, function and inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Evidence of oxidative stress in human corneal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Corneal autofluorescence in relation to permeability of the blood-aqueous barrier in diabetic patients with clinically significant macular edema and in an age-matched control group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Corneal and lens autofluorescence in young insulin-dependent diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Renoprotective effects of a novel inhibitor of advanced glycation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2806%2980068-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-4182(06)80068-2

1 reference

26 December 2017

1 reference

26 December 2017